Trials / Conditions / Primary Sjögren Syndrome

Primary Sjögren Syndrome

24 registered clinical trials studyying Primary Sjögren Syndrome — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Pr NCT07375524	Shanghai Escugen Biotechnology Co., Ltd	Phase 2
Recruiting	Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatm NCT07246096	Changhai Hospital	EARLY_Phase 1
Recruiting	Exploring the Novel Value of PSMA PET in Sjögren's Syndrome: Integrated Analysis With Established FAPI PET Ima NCT07324733	Peking Union Medical College Hospital	N/A
Recruiting	A Study of RSLV-132 in Females With Sjögren's Disease NCT06440525	Resolve Therapeutics	Phase 2
Enrolling By Invitation	Study on Optimization and Evaluation of Integrated Chinese and Western Medicine for pSS Glandular Damage NCT06519617	Qingwen Tao	Phase 2
Recruiting	Construction of Clinical Model of Primary Sjogren's Syndrome Combined Traditional Chinese and Western Medicine NCT06528197	China-Japan Friendship Hospital	—
Recruiting	Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases NCT06361745	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	N/A
Unknown	68Ga-P16-093 PET/CT Imaging in the Salivary Gland NCT06049368	Peking Union Medical College Hospital	Phase 1 / Phase 2
Unknown	A Study to Evaluate the Efficacy and Safety of Iguratimod Compared to Placebo in Patients With Active Primary NCT04830644	Jiangsu Simcere Pharmaceutical Co., Ltd.	Phase 2
Completed	Sjögren and Gynecologic Considerations NCT05670535	Ankara City Hospital Bilkent	—
Terminated	A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Prima NCT04700280	Galapagos NV	Phase 2
Completed	Cutaneous Silent Period Assessment in Primary Sjögren's Syndrome NCT05380804	Marmara University	—
Completed	Pilot Trial of Ustekinumab for Primary Sjögren's Syndrome NCT04093531	University of Rochester	Phase 1
Completed	Eye Dryness Evaluation in Primary Sjögren's Syndrome NCT03614299	University Hospital, Brest	—
Unknown	Biomarkers in Primary Sjögren's Syndrome NCT03765593	National Council of Scientific and Technical Research, Argentina	—
Recruiting	Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy NCT03509064	Assistance Publique - Hôpitaux de Paris	—
Unknown	LAMELLEYE for the Treatment of Dry Eye Symptoms in pSS Patients NCT03140111	NHS Greater Glasgow and Clyde	N/A
Completed	Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome NCT03226444	TearSolutions, Inc.	Phase 1 / Phase 2
Unknown	Inflammatory Myopathies in Primary Sjögren's Syndrome NCT03126383	University Hospital, Brest	—
Completed	Vaccine Coverage and Primary Sjögren'Syndrome NCT04224454	University Hospital, Montpellier	—
Completed	Effects of Primary Sjögren's Syndrome on Female Genitalia and Sexual Functions NCT04816370	Ankara Education and Research Hospital	N/A
Completed	Prognosis of Dental Implants in Patients With Primary Sjögren's Syndrome NCT04960605	University of Copenhagen	N/A
Completed	Resistance Exercise in Woman With Primary Sjörgen Syndrome. NCT03130062	Federal University of São Paulo	N/A
Completed	Neurotrophins Implications in Primary Sjögren Syndrome NCT01081184	University Hospital, Limoges	—